AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8729757 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha) therapy for 6 months
Number of subjects: 50
Study 8729757 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment for 6 months)
Number of subjects: 50
Study 2640224 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal and scattered photocoagulation applied over the affected area
Number of subjects: 20
Study 2640224 — intervention group
Group type: COMPARATOR
Intervention: Photocoagulation to reduce blood flow of the afferent arteriole
Number of subjects: 20
Study 894973 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified pilocarpine solution
Number of subjects: 30
Study 894973 — intervention group
Group type: COMPARATOR
Intervention: Pure pilocarpine solution
Number of subjects: 30
Study 31515141 — intervention group
Group type: EXPERIMENTAL
Intervention: Sm-TSP-2/Al with GLA-AF (30µg)
Number of subjects: 72
Study 31515141 — intervention group
Group type: EXPERIMENTAL
Intervention: Sm-TSP-2/Al with GLA-AF (100µg)
Number of subjects: 72
Study 31515141 — intervention group
Group type: EXPERIMENTAL
Intervention: Sm-TSP-2/Al without GLA-AF (10µg)
Number of subjects: 72
Study 31515141 — intervention group
Group type: EXPERIMENTAL
Intervention: Sm-TSP-2/Al without GLA-AF (30µg)
Number of subjects: 72
Study 31515141 — intervention group
Group type: EXPERIMENTAL
Intervention: Sm-TSP-2/Al with GLA-AF (10µg)
Number of subjects: 72
Study 31515141 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 72
Study 28461286 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended learning
Number of subjects: 1237
Study 28461286 — intervention group
Group type: COMPARATOR
Intervention: Pure e-learning
Number of subjects: 1237
Study 25371042 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (EX) - 60 minutes of running including eight 3-minute intervals at 90% VO2max before diving
Number of subjects: 16
Study 25371042 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) - No exercise before diving
Number of subjects: 16
Study 25371042 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EX and CON)
Number of subjects: 16
Study 24311384 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 529
Study 24311384 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 529
Study 21946291 — intervention group
Group type: EXPERIMENTAL
Intervention: Stay In Balance program (SIB)
Number of subjects: 135
Study 19228681 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted invitation to non-attenders combined with GP visits for quality enhancements
Number of subjects: 117129
Study 17181400 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Schools! BC (AS! BC) intervention including a daily jumping program (Bounce at the Bell) plus 15 minutes/day of classroom physical activity.
Number of subjects: 410
Study 17181400 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) of same-sex controls not participating in AS! BC.
Number of subjects: 410
Study 17181400 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Schools! BC (AS! BC) intervention.
Number of subjects: 410
Study 17181400 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON).
Number of subjects: 410
Study 15667046 — intervention group
Group type: EXPERIMENTAL
Intervention: VR group (neurofeedback with virtual reality)
Number of subjects: 28
Study 15667046 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-VR group (neurofeedback without virtual reality)
Number of subjects: 28
Study 15667046 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study 16372152 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative risk reduction
Number of subjects: 102
Study 16372152 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor response rate
Number of subjects: 102
Study 16372152 — intervention group
Group type: EXPERIMENTAL
Intervention: Median overall survival
Number of subjects: 102
Study 16372152 — intervention group
Group type: COMPARATOR
Intervention: Observation/supportive care
Number of subjects: 102
Study 16372152 — intervention group
Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 102
Study 16372152 — intervention group
Group type: COMPARATOR
Intervention: Surgery plus chemotherapy
Number of subjects: 102
Study 10547913 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal appointments (intervention group)
Number of subjects: 640
Study 10547913 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 640
Study 8893571 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative platelet-rich plasma (PRP) harvest
Number of subjects: 40
Study 8893571 — intervention group
Group type: COMPARATOR
Intervention: Control group (without PRP harvest)
Number of subjects: 40
Study 1830250 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-reduction program of diet, exercise, and behavior modification plus combination anorectic drug therapy (fenfluramine and phentermine)
Number of subjects: 52
Study 1830250 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 6294517 — intervention group
Group type: COMPARATOR
Intervention: ACTH
Number of subjects: 58
Study 6294517 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous cyclophosphamide plus ACTH
Number of subjects: 58
Study 6294517 — intervention group
Group type: COMPARATOR
Intervention: Plasma exchange, low-dose oral cyclophosphamide, and ACTH
Number of subjects: 58
Study 31496674 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol (IND) 150 μg q.d.
Number of subjects: 42
Study 31496674 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (TIO) 18 μg q.d.
Number of subjects: 42
Study 31496674 — intervention group
Group type: COMPARATOR
Intervention: Both IND and TIO
Number of subjects: 42
Study 29945934 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer-generation ultrathin strut drug-eluting stents (strut thickness <70 µm)
Number of subjects: 11658
Study 29945934 — intervention group
Group type: COMPARATOR
Intervention: Thicker strut second-generation drug-eluting stents
Number of subjects: 11658
Study 28039287 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity cycling intervention for 6 months
Number of subjects: 25
Study 28039287 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 fatty acids in plasma
Number of subjects: 25
Study 24809976 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-controlled ventilation with VT 6 ml/kg predicted body weight
Number of subjects: 28
Study 24809976 — intervention group
Group type: COMPARATOR
Intervention: Volume-controlled ventilation with VT 10 ml/kg predicted body weight
Number of subjects: 28
Study 24809976 — intervention group
Group type: EXPERIMENTAL
Intervention: Both VT groups
Number of subjects: 28
Study 21928256 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.2-mm trapezoidal corneal incision (TCI)
Number of subjects: 69
Study 21928256 — intervention group
Group type: COMPARATOR
Intervention: 5.2-mm scleral tunnel incision (STI)
Number of subjects: 69
Study 20118170 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering medication
Number of subjects: 355
Study 20118170 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge regarding optimal LDL levels
Number of subjects: 355
Study 20118170 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient engagement in treatment decisions
Number of subjects: 355
Study 20118170 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of medication requests
Number of subjects: 355
Study 20118170 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient inquiries about medication
Number of subjects: 355
Study 18567675 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular dexmedetomidine
Number of subjects: 60
Study 18567675 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine
Number of subjects: 60
Study 18567675 — intervention group
Group type: COMPARATOR
Intervention: Control (i.v. and intra-articular saline)
Number of subjects: 60
Study 16529667 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol 400 microg every 4 hours (to a maximum of four doses)
Number of subjects: 117
Study 16529667 — intervention group
Group type: COMPARATOR
Intervention: Intra-amniotic PGF2alpha 40 mg
Number of subjects: 117
Study 16529667 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 117
Study 10480263 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied three times per week for up to 16 weeks
Number of subjects: 19
Study 10480263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 10480263 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Number of subjects: 19
Study 8583605 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1
Number of subjects: 32
Study 8583605 — intervention group
Group type: COMPARATOR
Intervention: 3-drug mixture (17.64 mg/ml papaverine, 0.58 mg/ml phentolamine, 5.8 micrograms/ml prostaglandin E1)
Number of subjects: 32
Study 1918458 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin emollient 0.05% cream
Number of subjects: 0
Study 1918458 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin emollient 0.01% cream
Number of subjects: 0
Study 1918458 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin emollient 0.001% cream
Number of subjects: 0
Study 1918458 — intervention group
Group type: COMPARATOR
Intervention: Vehicle therapy
Number of subjects: 0
Study 31895867 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Storage Machine (ASM)
Number of subjects: 24
Study 31895867 — intervention group
Group type: COMPARATOR
Intervention: Conventional Organ Culture (OC)
Number of subjects: 24
Study 31326225 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrus microstent implantation after cataract surgery
Number of subjects: 331
Study 31326225 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification only
Number of subjects: 331
Study 26946148 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative duration of triple-low state (low MAP <65 mmHg, low BIS <45, low Ce <1.5 μg ml-1 of propofol anesthesia)
Number of subjects: 489
Study 26946148 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative duration of triple-low state
Number of subjects: 489
Study 26793128 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive enhancement therapy (CET)
Number of subjects: 14
Study 26793128 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 14
Study 23064511 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopic guidance
Number of subjects: 125
Study 23064511 — intervention group
Group type: EXPERIMENTAL
Intervention: CT anterior guidance
Number of subjects: 125
Study 23064511 — intervention group
Group type: EXPERIMENTAL
Intervention: CT posterior guidance
Number of subjects: 125
Study 23064511 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 125
Study 21629190 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14 capsules)
Number of subjects: 29
Study 21629190 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 29
Study 21629190 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group
Number of subjects: 29
Study 19443419 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (2 mg kg(‐1) h(‐1) during surgery and 1 mg kg(‐1) min(‐1) for the first 24 postoperative hours)
Number of subjects: 40
Study 19443419 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline 0.9%)
Number of subjects: 40
Study 19443419 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine infusion
Number of subjects: 40
Study 16462564 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed reduction and casting (n = 59)
Number of subjects: 113
Study 16462564 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed reduction and external fixation (n = 54)
Number of subjects: 113
Study 14742378 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (0.08 microg.kg(‐1).min(‐1), 40 min)
Number of subjects: 16
Study 14742378 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (600 mg)
Number of subjects: 16
Study 14742378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 11316241 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg i.v. Fe as Fe sucrose (Venofer, Vifor Int.) once per week for 5 doses + 2,000 IU EPO (Eprex, Cilag‐Janssen), subcutaneously for 5 doses
Number of subjects: 90
Study 11316241 — intervention group
Group type: COMPARATOR
Intervention: i.v. Fe alone (same dose as Group A)
Number of subjects: 90
Study 11316241 — intervention group
Group type: COMPARATOR
Intervention: i.v. Fe alone during follow-up
Number of subjects: 90
Study 11316241 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. Fe + EPO during follow-up
Number of subjects: 90
Study 9396542 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback therapy (2 to 8 sessions)
Number of subjects: 31
Study 7895957 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (experimental group, n = 16)
Number of subjects: 21
Study 7895957 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (control group, n = 5)
Number of subjects: 21
Study 3605568 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane with N2O and O2
Number of subjects: 76
Study 3605568 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane with N2O and O2
Number of subjects: 76
Study 30948068 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% GA
Number of subjects: 100
Study 30948068 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% GA
Number of subjects: 100
Study 30948068 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% GA
Number of subjects: 100
Study 30948068 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% EDTA
Number of subjects: 100
Study 30948068 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% citric acid (CA)
Number of subjects: 100
Study 30948068 — intervention group
Group type: EXPERIMENTAL
Intervention: GA and CA
Number of subjects: 100
Study 30948068 — intervention group
Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 100
Study 27821210 — intervention group
Group type: EXPERIMENTAL
Intervention: Asenapine 5 mg bid
Number of subjects: 311
Study 27821210 — intervention group
Group type: EXPERIMENTAL
Intervention: Asenapine 2.5 mg bid
Number of subjects: 311
Study 27821210 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine 15 mg once daily
Number of subjects: 311
Study 27821210 — intervention group
Group type: EXPERIMENTAL
Intervention: Asenapine (both doses)
Number of subjects: 311
Study 25842559 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior approach
Number of subjects: 66
Study 25842559 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior approach
Number of subjects: 66
Study 25842559 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined anterior and posterior approach
Number of subjects: 66
Study 22656044 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided treatment (clopidogrel non-responders received repeated loading doses of clopidogrel or prasugrel)
Number of subjects: 798
Study 22656044 — intervention group
Group type: COMPARATOR
Intervention: Non-guided treatment (clopidogrel non-responders did not undergo any change in treatment)
Number of subjects: 798
Study 22656044 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided treatment
Number of subjects: 798
Study 22656044 — intervention group
Group type: COMPARATOR
Intervention: Non-guided treatment
Number of subjects: 798
Study 21443324 — intervention group
Group type: EXPERIMENTAL
Intervention: Social PM tasks
Number of subjects: 0
Study 21443324 — intervention group
Group type: EXPERIMENTAL
Intervention: Social PM task
Number of subjects: 0
Study 19450044 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait positive affect (PA)
Number of subjects: 60
Study 19450044 — intervention group
Group type: COMPARATOR
Intervention: No Stress (reading task)
Number of subjects: 60
Study 19450044 — intervention group
Group type: COMPARATOR
Intervention: Stress (Trier Social Stress Test)
Number of subjects: 60
Study 17044935 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksite environmental intervention
Number of subjects: 515
Study 17044935 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 515
Study 15249618 — intervention group
Group type: EXPERIMENTAL
Intervention: Current hormone users
Number of subjects: 13807
Study 15249618 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term users of estrogen alone or combined with progestin
Number of subjects: 13807
Study 15249618 — intervention group
Group type: EXPERIMENTAL
Intervention: Women initiating hormones at older ages
Number of subjects: 13807
Study 15249618 — intervention group
Group type: COMPARATOR
Intervention: Never users
Number of subjects: 13807
Study 10789747 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan 40 mg containing 20 mg chlorpheniramine maleate (intramuscular)
Number of subjects: 60
Study 10789747 — intervention group
Group type: COMPARATOR
Intervention: Chlorpheniramine maleate (20 mg, intramuscular)
Number of subjects: 60
Study 9146776 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg lansoprazole
Number of subjects: 10
Study 9146776 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole
Number of subjects: 10
Study 9146776 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole
Number of subjects: 10
Study 9146776 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole
Number of subjects: 10
Study 9146776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 8377241 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 893
Study 8377241 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 893
Study 3099028 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosfomycin (FOM) otic solution
Number of subjects: 587
Study 30260372 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad administration of the Flanker Inhibitory Control and Attention Test
Number of subjects: 49
Study 30260372 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad administration of the Pattern Comparison Processing Speed Test
Number of subjects: 49
Study 30260372 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad administration of the Dimensional Change Card Sort Test
Number of subjects: 49
Study 30260372 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad administration of the List Sorting Working Memory Test
Number of subjects: 49
Study 30260372 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for iPad administration
Number of subjects: 49
Study 28601833 — intervention group
Group type: EXPERIMENTAL
Intervention: De-escalation from an empirical beta-lactam with antipseudomonal activity
Number of subjects: 0
Study 28601833 — intervention group
Group type: COMPARATOR
Intervention: Targeted narrow-spectrum antimicrobial
Number of subjects: 0
Study 25622970 — intervention group
Group type: EXPERIMENTAL
Intervention: Health literacy-informed, electronic health record-based strategy
Number of subjects: 600
Study 25622970 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 600
Study 23975325 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training with metformin
Number of subjects: 251
Study 23975325 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training without metformin
Number of subjects: 251
Study 23975325 — intervention group
Group type: COMPARATOR
Intervention: Resistance training
Number of subjects: 251
Study 23975325 — intervention group
Group type: COMPARATOR
Intervention: Combined aerobic and resistance training
Number of subjects: 251
Study 23975325 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting-list)
Number of subjects: 251
Study 21767015 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief family intervention (BFI)
Number of subjects: 256
Study 21767015 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 256
Study 19464546 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugate Haemophilus influenzae type b vaccine
Number of subjects: 0
Study 19464546 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine
Number of subjects: 0
Study 19464546 — intervention group
Group type: EXPERIMENTAL
Intervention: Native Indian infants
Number of subjects: 0
Study 19464546 — intervention group
Group type: EXPERIMENTAL
Intervention: Malnourished infants
Number of subjects: 0
Study 19464546 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated native Indian infants
Number of subjects: 0
Study 16451145 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane/fentanyl
Number of subjects: 49
Study 16451145 — intervention group
Group type: COMPARATOR
Intervention: TIVA (propofol/remifentanil)
Number of subjects: 49
Study 15010697 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg plus titrated dose of yohimbine (F/Y)
Number of subjects: 50
Study 15010697 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine 20 mg plus placebo (F/P)
Number of subjects: 50
Study 11379254 — intervention group
Group type: EXPERIMENTAL
Intervention: Mensendieck exercise programme (20 group sessions over 13 weeks)
Number of subjects: 77
Study 11379254 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylactic therapy, free to receive treatment or exercises)
Number of subjects: 77
Study 9715671 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration-production task during cognitive tasks (Stroop or card-sorting)
Number of subjects: 0
Study 9715671 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration-estimation task during cognitive tasks (Stroop or card-sorting)
Number of subjects: 0
Study 9715671 — intervention group
Group type: COMPARATOR
Intervention: Control group performing non-temporal tasks without timing tasks
Number of subjects: 0
Study 8026057 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (n = 115)
Number of subjects: 244
Study 8026057 — intervention group
Group type: EXPERIMENTAL
Intervention: Anistreplase (n = 129)
Number of subjects: 244
Study 8026057 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfusion grade 2
Number of subjects: 244
Study 8026057 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfusion grade 3
Number of subjects: 244